78. Hypopituitarism Clinical trials / Disease details
Clinical trials : 492 / Drugs : 341 - (DrugBank : 47) / Drug target genes : 45 - Drug target pathways : 100
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT05188131 (ClinicalTrials.gov) | October 1, 2021 | 1/12/2021 | Acute Neuroendocrine Response to Intravenous Infusion of Diclofenac Sodium | Acute Neuroendocrine Response to Intravenous Infusion of Diclofenac Sodium | Hypopituitarism | Drug: Intravenous Infusion of Diclofenac Sodium;Drug: Intravenous Infusion of Placebo | Azienda Ospedaliera Città della Salute e della Scienza di Torino | NULL | Completed | 20 Years | 50 Years | All | 12 | Phase 4 | Italy |